BC
RAPT

Boxer Capital’s RAPT Therapeutics RAPT Stock Holding History

Boxer Capital’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37,500
Closed -$4.99M – 66
2023
Q3 		$4.99M Hold
37,500
– – 0.27% 53
2023
Q2 		$5.61M Hold
37,500
– – 0.26% 55
2023
Q1 		$5.5M Buy
+37,500
New +$7.58M 0.27% 48

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Boxer Capital's RAPT Position: Q4 2023 in Review

Boxer Capital sold out of RAPT Therapeutics (RAPT) in Q4 2023, closing a stake of 37,500 shares — an estimated $4.99M sold.

Boxer Capital first reported a position in RAPT in Q1 2023 and held it in 3 quarters. The position peaked at $5.61M in Q2 2023. 108 funds tracked by Wall St. Rank hold RAPT as of Q4 2023.

  • Boxer Capital reported no remaining RAPT Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Boxer Capital sold 37,500 RAPT Therapeutics shares in Q4 2023, an estimated $4.99M.
  • Boxer Capital first reported a position in RAPT Therapeutics in Q1 2023 and held it in 3 quarters.
  • Boxer Capital's RAPT Therapeutics position peaked at $5.61M in Q2 2023.
  • 108 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2023.

Based on Boxer Capital's 13F filing for Q4 2023, filed 14 Feb 2024.